Identification and control of an outbreak of ciprofloxacin-susceptible EMRSA-15 on a neonatal unit
Related Experiment Video
Updated: Jul 10, 2026

Isolation and Identification of Waterborne Antibiotic-Resistant Bacteria and Molecular Characterization of their Antibiotic Resistance Genes
Published on: March 3, 2023
J A Otter1, J L Klein, T L Watts
1Infection and Immunology Delivery Unit, St Thomas' Hospital and King's College London, London, UK.
Abstract:
We report the identification and control of an outbreak of a ciprofloxacin-susceptible strain of UK epidemic meticillin-resistant Staphylococcus aureus (EMRSA)-15 on a neonatal unit (NNU). All babies were screened for MRSA on admission using ciprofloxacin-containing media which did not detect the outbreak strain. The first identified case was a premature baby who developed MRSA bacteraemia with associated tibial osteomyelitis and multiple subcutaneous abscesses. The outbreak strain was subsequently identified in the nasopharyngeal secretions of a second child who was not clinically infected. Screening of all patients on the NNU using non-ciprofloxacin-media identified two other colonised babies. All four patient isolates were EMRSA-15, spa type t022, SCCmec IV, Panton-Valentine leucocidin (PVL) negative, indistinguishable by pulsed-field gel electrophoresis and susceptible to all non-beta-lactam antimicrobials tested. The outbreak strain was cultured from four of 48 environmental sites in a communal milk-expressing room. Unsupervised movement of mothers to and from the milk-expressing room may have contributed to the outbreak. Control measures included cohort isolation of affected babies, improved environmental cleaning, increased emphasis on hand hygiene and education of mothers. Ciprofloxacin-containing media should be used with caution for MRSA screening in settings where ciprofloxacin-susceptible strains (including community-associated MRSA) are increasing in prevalence.
Insights
An outbreak of ciprofloxacin-susceptible meticillin-resistant Staphylococcus aureus (MRSA) EMRSA-15 occurred on a neonatal unit. Standard screening failed to detect the strain, highlighting the need for caution with ciprofloxacin-containing media.
Area of Science:
- Medical Microbiology
- Infectious Disease Epidemiology
- Neonatal Care
Background:
- Meticillin-resistant Staphylococcus aureus (MRSA) outbreaks pose significant risks in neonatal units.
- Standard screening methods may not detect all circulating MRSA strains, particularly those with altered susceptibility patterns.
Purpose of the Study:
- To identify and control an outbreak of a specific MRSA strain on a neonatal unit.
- To evaluate the effectiveness of standard screening protocols and implement targeted control measures.
Main Methods:
- Screening of neonates on admission using ciprofloxacin-containing media.
- Identification of MRSA isolates, including molecular typing (spa type, SCCmec type) and antimicrobial susceptibility testing.
- Environmental screening and investigation of potential transmission routes.
- Implementation of infection control measures including cohort isolation, enhanced cleaning, and hand hygiene.
Main Results:
- An outbreak of ciprofloxacin-susceptible EMRSA-15 (ST30, SCCmec IV, PVL-negative) was identified.
- Initial screening with ciprofloxacin-containing media failed to detect the outbreak strain.
- The strain was found in four neonates (one with invasive disease) and environmental samples.
- Control measures successfully contained the outbreak.
Conclusions:
- Ciprofloxacin-containing media may fail to detect ciprofloxacin-susceptible MRSA strains, necessitating careful consideration in screening protocols.
- Enhanced infection control practices, including environmental hygiene and maternal education, are crucial for managing MRSA outbreaks in neonatal settings.
- The unsupervised movement of mothers in communal areas may have facilitated transmission.
Related Concept Videos
Clinical Significance of Antibiotic Resistance
Mechanism of Antibiotic Resistance in MRSA
Investigation of Disease Outbreaks
Healthcare Associated Infections II: Preventive Measures
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
